Skip to main content
University of Wisconsin-Madison

Funding awarded for lung cancer research

Jill M. Kolesar, professor (CHS) in the Pharmacy Practice Division, has received funding to support two clinical trials on lung cancer research from the Frontier Science & Technology Research Foundation, Inc. (FSTRF)

Based at UW Carbone Cancer Center, the trials will focus on development of a model to predict progression free survival after treatment with Erlotinib.

FSTRF is a not-for-profit research foundation established to advance the application of statistical science and practice and data management techniques in science, health care, and education. The Foundation is currently engaged in large-scale national and international clinical trials related to the treatment of cancer and AIDS patients.